secwatch.observer — SEC 8-K summary
======================================

Issuer:     COLLEGIUM PHARMACEUTICAL, INC (COLL)
CIK:        0001267565
Form:       8-K
Filed at:   2023-02-13T23:59:59+00:00
Accession:  0001104659-23-019671
Event type: debt
Sentiment:  neutral
Materiality: 0.65
Item codes: 1.01, 2.03, 3.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Collegium prices $241.5M convertible notes offering, repurchases $117.4M of 2026 notes
--------------------------------------------------------------------------------

- Priced $210M convertible notes offering, upsized to $241.5M with full exercise of initial purchasers' option.
- Notes bear 2.875% interest, mature Feb 2029; initial conversion price $36.56/share, ~30% premium to $28.12.
- Net proceeds estimated at $203.2M ($233.8M if greenshoe fully exercised) after discounts and expenses.
- Used $140.1M to repurchase $117.4M of its 2.625% convertible notes due 2026.
- Remainder for general corporate purposes including business development and capital allocation.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1267565/000110465923019671/0001104659-23-019671-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1267565/000110465923019671/tm235915d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-23-019671

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer